Real-time enrollment status for this systemic mastocytosis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 2:15 AM UTC
| NCT Number | NCT04910685 |
| Recruiting Status | Recruiting |
| Condition | Systemic Mastocytosis |
| Phase | PHASE2 |
| Target Enrollment | 534 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Blueprint Medicines Corporation |
| Last Updated on CT.gov | June 25, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT04910685 is currently recruiting participants. This phase2 study for systemic mastocytosis is actively seeking new participants at 14 locations across the United States. The study is sponsored by Blueprint Medicines Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04910685 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04910685 was last updated 3 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.